“BETTER THAN BOTOX?”

RSB Dermatology

Revance Therapeutics Inc. said that an experimental drug RT002 [injectable daxibotulinumtoxinA] can smooth wrinkles for longer than Allergan’s Botox, according to the results of late-stage studies. We will have to wait for the published data to see, but at least early reports look promising.

Read More

A BOTOX AND DYSPORT COMPETITOR: THE FDA APPROVED XEOMIN FOR THE TREATMENT OF FROWN LINES.

RSB Dermatology

Merz Aesthetics announced that the FDA has approved incobotulinum toxin A (Xeomin) for the temporary improvement in the appearance of frown lines. This product was approved by the FDA in July of 2010 for the treatment of cervical dystonia and blepharospasm, but has recently been approved for cosmetic use in the U.S.A.  This product has been…

Read More